In 2005, in the United States, 104,000 new end-stage renal disease (ESRD) patients initiated renal replacement therapy with 97,143 starting hemodialysis (HD), 6875 peritoneal dialysis (PD), and 2424 receiving a preemptive transplant. 1 The importance of providing education to patients to enable them to intelligently participate in making choices in terms of modality selection for ESRD has been emphasized in several recent publications. [2] [3] [4] [5] Of particular significance are the observations that adequate chronic kidney disease (CKD) education can delay the onset of dialysis, increase patient choice of less costly home-based therapies, and improve outcomes of patients after the start of dialysis. 4, 5 Nevertheless, there are many barriers to providing education for the patient with CKD. The care of the patients is complex and physician time constraints often limit the ability to provide adequate patient education. Funding for trained individuals to provide CKD education is often not available. Moreover, few published studies provide guidelines on how to provide CKD education.
In terms of modality selection when patients approach ESRD, nephrologists have reported that patient choice is the most important factor in choosing a dialysis therapy. 6 Yet, the majority of patients who approach ESRD do not have adequate knowledge of the different therapeutic options. 7 CRIOS, the CKD RenalSoft Informatics Observational Study, is a prospective observational study designed to identify trends in practice patterns and outcomes in CKD patients. One of the goals of this study is to examine the perceived knowledge and education of CKD patients concerning therapeutic options for ESRD.
RESULTS
Of the 2295 patients enrolled in the CRIOS study, 823 completed education assessment questionnaires. Of these 823 patients, clinical data and CKD stage identification were available for 749 patients; of these, there were 676 patients that were CKD stage 3-5. All analyses used data from these 676 patients. When comparing the patients completing the questionnaire with those not completing the questionnaire, the groups were the same in terms of age and percent with diabetes; but the patients completing the questionnaire had a slightly lower glomerular filtration rate (23.5 vs 28.7), and had a slightly lower percent of women (42 vs 47%). Table 1 provides a summary of the demographic data on these 676 patients; 24% were stage 3, 56% stage 4, and 20% stage 5 patients.
The duration of nephrology care before entering the study ranged from 0 to 50 years, with a mean of 5.2 years and a median of 2 years. Patients (65%) had been seen by a nephrologist for X1 year.
When patients were asked about their general level of knowledge concerning their kidney disease, only 23% of patients reported having a great deal or extensive knowledge; 35% reported having very limited or no knowledge about their kidney disease. Their kidney disease was a source of concern for the patients. When asked to rate their 'worry about their kidney disease' over the preceding 4 weeks on a 0-10 scale (0 being not at all and 10 being extremely worried), 8% of patients were extremely worried (score of 10), 29% of patients rated their worry as 6 or greater, and an additional 21% rated their worry as 3 or 4.
A total of 43% of patients reported having no knowledge of HD, 57% had no knowledge of continuous ambulatory peritoneal dialysis (CAPD), 66% had no knowledge of automated PD, and 56% had no knowledge of transplantation ( Table 2) . Total 35% of patients had no knowledge of any therapeutic modality for ESRD.
There was a significant improvement in patients' perception of their knowledge of modalities with increased frequency of nephrology visits in the preceding year (Table 3) . Thus, 64% of patients who had four or more visits in the preceding year reported having knowledge of transplantation and HD compared to only 40% (HD) and 45% (transplant) of patients seen only once during the past year. CAPD knowledge reportedly improved from 25 to 51% with the increased frequency of visits.
It is of interest that as CKD stage progressed, reported knowledge of all modalities improved significantly. Among stage 5 patients, 70% reported knowledge of transplant, 65% of CAPD, and 79% of HD ( Table 4 ).
The relationship between perceived knowledge of various ESRD therapies was then correlated with patients' perception of their understanding of the advantage and disadvantages of the available treatment options ( Table 5 ). What is striking is that the vast majority of patients reporting no knowledge of the various therapies indicated that they did not know about the advantages and disadvantages of the various treatment options. For example, 70.5% of patients reporting having no knowledge of any ESRD therapy reported having no knowledge of the advantages and disadvantages of these therapies.
The effects of gender, diabetes, race, and patient educational level on the perceived knowledge of renal replacement therapies were then explored. Gender and diabetes had no correlation with level of knowledge. Race, however, was important; African-American (AA) patients had less perceived knowledge of renal replacement therapies in general ( Table 5 ). This was particularly true for PD; 23% of AA reported perceived knowledge of PD compared to 42% of Caucasians and 67% of Asians (Po0.001; Table 6 ). Perceived knowledge of HD was also significantly lower among AA (34%) than for Caucasians (58%) or Asians (88%) (P ¼ 0.002). The patient educational level also had an impact on the level of perceived knowledge concerning various therapies. For example, patients who had a college education reported significantly more knowledge of HD (67%) compared to patients with lower levels of education (53%,
Of the patients completing the questionnaires, 86% were Canadian. Significantly more of the US vs Canadian patients reported no knowledge of the various ESRD therapies ( Table 7) . For example, 52% of the US patients reported no knowledge of any ESRD therapy compared to only 33% of Canadian patients.
DISCUSSION
The present study suggests that a large percent of CKD patients (stage 3-5) report having limited knowledge about their kidney disease and no knowledge of the various therapeutic modalities for ESRD. This is surprising as the patients had been followed by nephrology practices for a mean of 4.8 years and a median of 2 years. More reported knowledge was associated with increasing frequency of nephrology visits during the preceding year and with a more advanced stage of kidney disease. However, it is noteworthy that perceived knowledge of peritoneal dialysis was lower than knowledge of HD or transplant at all stages of CKD and at all levels of frequency of nephrology visits. This suggests that PD is either not presented to patients or is presented to patients in a manner in which they are not able to process the information. It appears that the delivery of information to AAs in terms of therapeutic modalities, particularly CAPD, is less successful than to Asians or Caucasians.
These findings are particularly important in several respects. First, studies by Devins have suggested that education of CKD patients can delay the onset of dialysis and improve patient outcomes after they start dialysis. 3, 4 Second, studies have shown that provision of educational programs for patients with CKD can increase the percent of patients who will start dialysis with less expensive self-care (including home-based therapies) as opposed to traditional, facility-based, standard care dialysis. 8 Third, it has been shown in various chronic diseases that patient education programs and patient knowledge can have a positive impact on medical outcomes. [9] [10] [11] [12] The problems in providing adequate education for CKD patients are well documented. 7 It has been suggested that this difficulty in part reflects lack of referral to nephrologists for care. 7 However, the present findings suggest that even in patients seen by nephrologists, the levels of patient perception of knowledge about CKD and therapeutic options for ESRD are limited. Perceived levels of knowledge improve with increased frequency of nephrology visits and stage of CKD. However, in patients who had four or more visits with nephrologists in the preceding year, 35% of patients did not report knowing about HD or transplantation and 50% about CAPD.
Does the reported lack of knowledge actually mean that the patients do not know about their CKD and various ESRD therapies? It is indeed possible that the perceived lack of knowledge may not in fact reflect actual lack of knowledge. Therefore, the finding that the patients who did not report knowledge also did not report understanding the advantages and disadvantages of different therapeutic options if their kidney disease worsened is critically important. The ability of patients to make informed decisions about appropriate ESRD therapies as their CKD progresses will be compromised by their lack of reported knowledge of the advantages and disadvantages of the various therapies. The challenge for nephrologists then is to better understand the barriers that limit effective communication with patients so that the patients' perception of knowledge as well as their actual knowledge of ESRD treatments improves. Patients then and only then will be equipped and empowered to more effectively participate in decision-making regarding their care, such as decisions about therapeutic modalities for ESRD.
The reasons for these perceived knowledge deficiencies are not clear. It may reflect the difficulties in communicating with and educating patients given the time constraints of follow-up visits and complexity of CKD patient care. The high level of 'worry' expressed by patients concerning their CKD may pose barriers to effective communication to patients about their disease. It is of note that patients with at least some college education reported having higher levels of knowledge than those with lower levels of education, suggesting that an educational background facilitates, in some way, patients' ability to report understanding of their kidney disease.
Of particular concern is the significantly greater lack of perceived knowledge reported by AA patients, supporting the findings of other investigators examining other chronic diseases. [13] [14] [15] Given the strikingly lower level of perceived knowledge of AA about PD, it is possible this limits the access of AA to this therapy. Other investigators have described limitations in access to a variety of procedures in AA patients. 15 It is important and concerning to note that our findings are based on predominantly Canadian patients, who compromise 86% of the respondents to the educational questionnaire. Not surprisingly, Canadian patients reported more knowledge than the US patients. In Canada, in general, the centralization of dialysis and other renal services in acute care hospitals allows for complete integration of CKD clinics, with home-based dialysis and in-center dialysis. Canadian nephrologists have easier access to multidisciplinary teambased CKD care, which includes professional services provided by nurse educators, social workers, dieticians, and pharmacists. 16 In some provinces, funding for infrastructure and nonmedical personnel is paid directly to the facility by the government, whereas in others, monies from the renal global budget are controlled by the program, which can determine how much should be spent on pre-ESRD clinics or on other activities. In contrast, in the United States, there is no integration of care of patients with CKD stages 3-5 not yet on dialysis with subsequent dialysis care. In general, CKD care is provided by nephrologists in private office settings. Nephrologists are paid fee for service for consultations and follow-up care, but there is no current funding arrangement to compensate the nephrologist or other caregivers for renal education about treatment modalities. Access to dietary or social work consultations for CKD patients is limited. The importance of the recent legislation that has passed the House of Representatives to provide funding to support CKD patient education in the United States, therefore, deserves special attention.
There are some limitations to the present study. The study is a nonrandomized, cohort study of patients followed in existing nephrology clinics. The majority of the patients completing the questionnaire were Canadian. Only 676 of 2295 patients completed the survey questionnaire and thus our findings may not be generalizable to the entire CKD population. Patient education was assessed by questionnaire with patients reporting their perceived level of knowledge. Actual patient knowledge was not tested. Education may well have been received but not recalled or indicated by the patients. Future studies may well want to address the impact of patient education programs on actual rather than perceived knowledge.
The present study highlights that one of the challenges for nephrologists is developing new programs or enhancing existing ones to provide adequate education for CKD patients. The hypothesis that lack of knowledge of CKD patients concerning their disease reflects late referrals to nephrologists is only a part of the problem. The lack of effective education programs after nephrology referral is another dimension that deserves further study and investigation. Particular emphasis needs to be placed In its entirety, the CRIOS study was designed to collect data on clinical care practices, selection of patients for specific renal replacement therapy, access planning and placement, quality of life, and the impact of patient educational intervention. The data were entered into a software application, used as a clinical management tool, at each site (RenalSoft, Baxter Healthcare Corporation), and, on a monthly basis, patient information was de-identified and forwarded to a central data repository.
Patients with CKD were continuously enrolled throughout the duration of the study. Inclusion criteria included: (1) glomerular filtration rate o60 ml/min per 1.73 m 2 (CKD stages 3-5, not on dialysis) (2) age 18 and older, (3) ability to read and communicate in English or French. Patients remained in the program until they began renal replacement therapy, died, or transferred care to another program. Information regarding demographics, health care delivery, prescriptions, preeducational assessment, renal replacement therapy choices, and access planning and placement information was collected at baseline and on an ongoing basis at time of physician or educator interaction. All data collected, other than the patient educational assessments and patient quality of life survey, were data that were routinely obtained during a normal clinic visit, and/or through usual care of the patient. No additional clinic visits or testing was required.
All enrolled patients who agreed to participate in the study were asked to complete a self-administered survey, to determine their knowledge of CKD and renal replacement therapies. The assessments were administered while patients were receiving the standard of care at their facility. The questions were focused on the following areas: (1) the length of time patients were seen by a nephrologist; (2) when patients were first told of their kidney disease, (3) the frequency of nephrology visits, (4) patients' understanding of basic principles of CKD treatment options, (5) patients' understanding of the advantages and disadvantages of available treatments if there kidney disease worsens, (6) patients' level of anxiety about their CKD, and (7) patients' interest in obtaining further education related to kidney disease and renal replacement therapies. The questionnaire is summarized in Appendix A. Total 86% of patients completing the questionnaire were from Canadian centers.
Statistical methods
Tests (w 2 ) were used to measure the strength of the association of the knowledge of HD, PD, and kidney transplantation to various other factors (frequency of nephrology visits in the preceding year, CKD stage, gender, diabetic status, race, and education level).
DISCLOSURE
The authors state no conflict of interests. When were you first told you had a problem with your kidneys? ____________ At today's visit to the doctor OR ____________ weeks ago (enter a value between 1 and 4) OR ____________ months ago (enter a value between 1 and 12) OR ____________ one or more years ago (enter a value greater than 1)
3)
When was the first time you saw a nephrologist (kidney doctor)? ____________ At today's visit to the doctor OR ____________ weeks ago (enter a value between 1 and 4) OR ____________ months ago (enter a value between 1 and 12) OR ____________ one or more years ago (enter a value greater than 1)
4)
How many times did you see your nephrologist in the past year? ____________ times(if this is you first visit, enter 0)
5)
Do you know what is causing your kidney disease?
In this 'next section, please think about various options that are available for patients with kidney disease. You may or may not have ever heard of these options. Please choose the response which most closely reflects how much knowledge you have about each option.
